Cable Viewer

Currently released so far... 12433 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AORC AF AR ASEC AEMR AMGT AE ABLD AL AJ AU AO AFIN ASUP AUC APECO AM AG APER AGMT AMED ADCO AS AID AND AMBASSADOR ARM ABUD AODE AMG ASCH ARF ASEAN ADPM ACABQ AFFAIRS ATRN ASIG AA AC ACOA ANET APEC AQ AY ASEX ATFN AFU AER ALOW AZ APCS AVERY ASECKFRDCVISKIRFPHUMSMIGEG AN AGRICULTURE AMCHAMS AINF AGAO AIT AORL ACS AFSI AFSN ACBAQ AFGHANISTAN ADANA AX AECL AADP AMEX ACAO AORG ADM AGR AROC
BL BR BO BE BK BY BA BILAT BU BM BEXP BF BTIO BC BBSR BMGT BTIU BG BD BWC BH BIDEN BB BT BRUSSELS BP BX BN
CD CH CM CU CBW CS CVIS CF CIA CLINTON CASC CE CR CG CO CJAN CY CMGT CA CI CN CPAS CAN CDG CW CONDOLEEZZA CT CIC CIDA CSW CACM CB CODEL COUNTERTERRORISM CTR COUNTER CWC CONS CITEL CV CFED CBSA CITT CDC COM COE COUNTRY CLEARANCE CDB CKGR CACS CARSON CROS CAPC CHR CL CICTE CIS CNARC CJUS CEUDA CLMT CAC COPUOS CBC CBE CARICOM CTM CVR
DR DPRK DEPT DA DJ DEA DTRA DOMESTIC DHS DAO DCM DO DE DEAX DOE DK DS DISENGAGEMENT DOD DEFENSE
EAGR EAIR ECON ECPS ETRD EUN ENRG EINV EMIN EU EFIN EREL EG EPET ENGY ETTC EIND ECIN EAID ELAB EC EZ ENVR ELTN ELECTIONS ER EINT ES EWWT ENIV EAP EFIS ERD ENERG EAIDS ECUN EI EINVEFIN EN EUC EINVETC ENGR ET ETRDEINVECINPGOVCS ECONOMY EUMEM ESA EXTERNAL EINVECONSENVCSJA EINN EEPET ENVI EFTA ESENV ECINECONCS EPA ECONOMIC ETRA EIAR EUREM ETRC EXBS ELN ECA EK ECONEFIN ETC ETRDECONWTOCS EUNCH ECIP EINDETRD EUR ENNP EXIM ERNG EFINECONCS ETRDEINVTINTCS ETRO EDU ETRN EFIM EAIG EURN ECONCS ECONOMICS
FR FREEDOM FTA FI FOR FJ FTAA FARC FINANCE FDA FAC FBI FAO FM FMLN FO FISO FOREIGN FOI FAS FINR
GM GE GG GZ GOV GT GR GAERC GV GH GA GY GOI GTIP GCC GERARD GAZA GTMO GL GLOBAL GANGS GF
HO HA HILLARY HUMAN HR HURI HEBRON HU HK HUMOR HSTC HI HYMPSK
IS ICRC IN IR IZ IT INRB IAEA ICAO ITALY ITALIAN IRAQI IC IL ID IV IMO INMARSAT IQ IRAJ IO ICTY IPR IWC ILC INTELSAT IBRD IMF IRC IRS ILO ITU IDA IAHRC ICJ ITRA ISRAELI ITF IACI IDP ICTR IIP IA IF IZPREL IGAD INTERPOL INTERNAL ISRAEL ISLAMISTS INDO ITPHUM ITPGOV IBET IEFIN INR INRA INRO IEA
JA JAMES JO JM JOSEPH JP JOHNNIE JOHN JUS
KSCA KUNR KHLS KAWK KISL KPAO KSPR KGHG KPKO KDEM KNNP KN KS KPAL KACT KCRM KDRG KJUS KGIC KRAD KU KTFN KV KMDR KWBG KSUM KSEP KCOR KHIV KG KGCC KTIP KIRF KE KIPR KMCA KCIP KTIA KAWC KBCT KVPR KPLS KREL KCFE KOMC KFRD KWMN KTDB KPRP KMFO KZ KVIR KOCI KMPI KFLU KSTH KCRS KTBT KIRC KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFLO KSTC KFSC KFTFN KIDE KOLY KMRS KICA KCGC KSAF KRVC KVRP KCOM KAID KTEX KICC KNSD KBIO KOMS KGIT KHDP KNEI KTRD KWNM KRIM KSEO KR KWAC KMIG KIFR KBTR KTER KDDG KPRV KPAK KO KRFD KHUM KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KREC KCFC KLIG KWMNCS KSEC KPIN KPOA KWWMN KX KCMR KPWR KCHG KRGY KSCI KNAR KFIN KBTS KPAONZ KNUC KNPP KDEMAF KNUP KNNPMNUC KERG KCRCM KWMM KPAI KHSA KTLA KRCM KCSY KSAC KID KOM KMOC KESS KDEV KJUST
LE LY LI LH LAB LU LG LOG LTTE LA LO LABOR LT
MARR MOPS MX MASS MNUC MCAP MO MU ML MA MTCRE MY MOPPS MASC MIL MR MTS MLS MILI MK MEPP MD MAR MP MTRE MCC MZ MDC MRCRE MV MI MEPN MAPP MEETINGS MAS MTCR MG MEPI MT MEDIA MASSMNUC MQADHAFI MPOS MAPS MARAD MC MIK MUCN MILITARY MERCOSUR MW
NZ NL NATO NO NI NU NATIONAL NG NP NPT NPG NS NA NSG NAFTA NC NH NE NSF NSSP NDP NORAD NK NEW NR NASA NT NIPP NAR NGO NW NV NATOPREL NPA NRR NSC NSFO NZUS
OTRA OVIP OEXC OIIP OSAC OPRC OVP OFFICIALS OAS OREP OPIC OSCE OECD OSCI OFDP OPDC OIC OFDA ODIP OBSP ON OCII OES OPCW OPAD OIE OHUM OCS OMIG OTR
PGOV PREL PARM PHUM PREF PTER PINS PK PINR PROP PBTS PKFK PL PE PSOE PEPR PM PAK POLITICS POL PHSA PPA PA PBIO PINT PF PFOR PHALANAGE PARTY PNAT POLINT PRAM PMAR PG PAO PROG PRELP PCUL PSEPC PGIV PO PREFA PALESTINIAN PGOVLO PGOVE PLN PINF PAS PDEM PHUMPGOV PNG PHUH PMIL POGOV PHUMPREL PHUS PRL PGOC PNR PGGV PROV PHUMBA PEL PECON POV PSA PREO PAHO PP PSI PINL PU PARMS PRGOV PAIGH POLITICAL PARTIES POSTS PTBS PORG PUNE POLICY PDOV PCI PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PS PY PTERE PGOF
QA
RS RO RU RW REGION RIGHTS RSP ROBERT RP RICE REACTION RCMP RFE RM RIGHTSPOLMIL RF ROOD RUPREL RSO RELATIONS REPORT
SENV SZ SOCI SNAR SP SCUL SU SY SA SO SF SMIG SW STEINBERG SG SIPRS SR SI SPCE SN SYRIA SL SC SHI SNARIZ SIPDIS SPCVIS SH SOFA SK ST SEVN SYR SHUM SAN SNARCS SAARC SARS SEN SANC SCRS SENVKGHG SNARN SWE SSA
TPHY TW TS TU TX TRGY TIP TSPA TSPL TBIO TNGD TI TFIN TC TRSY TZ TINT TT TF TN TERRORISM TP TURKEY TD TH TBID TL TV TAGS TK TR THPY TO
UNGA UNSC UNCHR UK US UP UNEP UNMIK UN UAE UZ UG UNESCO UNHRC USTR UNHCR UY USOAS UNDC UNCHC UNO UNFICYP USEU UNDP UNODC UNCND UNAUS UNCHS UV USUN USNC UNIDROIT UNCSD UNICEF UE UNC USPS UNDESCO UNPUOS USAID UNVIE
VE VT VZ VTPREL VM VN VTIZ VAT VC VTEG VI
WMO WTRQ WB WI WWARD WA WBG WITH WHA WTO WMD WTRO WIPO WHO WS WHTI WEU WZ WFP
XB XG XT XH XA XM XF XE XR XK XL XW XY XS XX XV XD XTAG XQ XU XZ XC XI
YM YE YI YMCS
ZI ZP ZR ZO ZF ZANU ZOELLICK ZU ZL ZEALAND ZN ZB ZA ZK ZJ

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 06WELLINGTON475, INDUSTRY SEES HIGHER COSTS UNDER NEW ZEALAND-AUSTRALIA

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #06WELLINGTON475.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
06WELLINGTON475 | 2006-06-21 23:11 | 2011-04-28 00:12 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Embassy Wellington

`

    VZCZCXRO6701
    RR RUEHNZ
    DE RUEHWL #0475/01 1722314
    ZNR UUUUU ZZH
    R 212314Z JUN 06
    FM AMEMBASSY WELLINGTON
    TO RUEHC/SECSTATE WASHDC 2921
    INFO RUCPDOC/USDOC WASHDC 0062
    RUEHNZ/AMCONSUL AUCKLAND 0791
    RUEHBY/AMEMBASSY CANBERRA 4458
    RUEHDN/AMCONSUL SYDNEY 0448

` `

    UNCLAS SECTION 01 OF 02 WELLINGTON 000475

    SIPDIS

    SENSITIVE
    SIPDIS

    STATE PASS USTR-JJENSEN
    STATE PASS FDA FOR OFFICE OF INTERNATIONAL PROGRAMS
    STATE FOR EAP/ANP-DRICCI AND EB/TPP/BTA/ANA-MBGOODMAN
    COMMERCE FOR ABENAISSA/4530/ITA/MAC/AP/OSAO
    SYDNEY FOR CS

    E.O. 12958: N/A
    TAGS: ETRD ECON NZ
    SUBJECT: INDUSTRY SEES HIGHER COSTS UNDER NEW ZEALAND-AUSTRALIA
    REGULATORY AGENCY

    REF: (A) 05 WELLINGTON 119; (B) 04 WELLINGTON 596

    ¶1. (SBU) Begin summary:  Proposed rules for a new Australian-New
    Zealand regulatory agency for therapeutic products will make it
    costlier for U.S. makers of medical devices and complementary
    medicines to operate in New Zealand, according to the manufacturers'
    representatives.  They contend the proposed rules, issued May 23,
    would drive many of their products out of New Zealand.  In contrast,
    the pharmaceutical industry expects the agency would expedite the
    process for obtaining marketing approval for medicines and would
    save the industry in regulatory costs.  Its support of the agency,
    however, hinges on the New Zealand government continuing to allow
    direct-to-consumer advertising of prescription drugs, which is not
    allowed in Australia.  Meanwhile, the government does not yet have
    enough political support to pass the legislation necessary to set up
    the agency.  End summary.

    ¶2. (U) Australia and New Zealand signed an agreement in December
    2003 to provide unified regulation of prescription pharmaceuticals
    as well as therapeutic goods that have been virtually unregulated in
    New Zealand, including medical devices, over-the-counter medicines,
    dietary and nutritional supplements, and cosmetics and toiletries
    (ref B).  The proposed agency -- the Australia New Zealand
    Therapeutic Products Authority -- would replace the Australian
    Therapeutic Goods Administration (TGA) and the New Zealand Medicines
    and Medical Devices Safety Authority (Medsafe).  The deadline for
    public submissions on the draft rules is August 15.  The New Zealand
    government is hoping to introduce legislation in July to establish
    the agency and open the agency's doors in the second half of 2007.

    ¶3. (SBU) The agency's opening has been delayed a number of times
    previously (ref A), and passage of the implementing legislation is
    far from certain.  The Labour-led New
    Zealand government lacks the votes in Parliament to pass the
    legislation on its own and has no support yet from any other party.
    Some opponents are concerned about Australia's possible dominance of
    the agency, and others are worried that it would mean higher costs
    for industry and consumers in New Zealand.  Proponents say that New
    Zealand's participation in the joint agency would cost less than if
    it tried on its own to extend its regulatory authority to devices
    and other non-drug health products.

    Medical devices, complementary medicines
    ----------------------------------------
    ¶4. (SBU) Under the proposed rules, the agency would require licenses
    for all therapeutic goods and recover all its regulatory costs
    through fees and charges.  That would be particularly burdensome for
    New Zealand's medical device and complementary medicine sectors,
    which have not been required to obtain pre-market approval for their
    products and pay no licensing or other regulatory fees.  While the
    draft rules provide for a three-year transition period for product
    licenses to be obtained, industry representatives expect the fees to
    be so high that they will have to seek cheaper sources -- outside
    the United States -- for medical devices and complementary
    medicines.  They expect the fees to be similar to those already
    charged in Australia, which has a population and market roughly five
    times as large as New Zealand's.  They predict the compliance costs
    would force many smaller distributors and importers out of business
    in New Zealand.

    ¶5. (SBU) The draft rules also provide that the agency would conduct
    all conformity assessments for medical devices, including audits of
    manufacturers and testing of products to ensure they meet relevant
    standards, which also would increase the sector's costs.  Medical
    device representatives noted that the proposed agency would accept
    European certification, but not U.S. Food and Drug Administration
    certification.  As one representative said, that points to the need
    for a mutual recognition agreement between Australia and the United
    States, which presumably would enable the joint agency to accept FDA
    certification.

    ¶6. (SBU) The industry representatives said they support the agency
    in principle, recognizing the need for regulation of their products
    to ensure public safety.  However, they were disappointed that their
    years of consultations with the government about their concerns
    regarding a new regulatory regime were not reflected in the
    proposal.  They had hoped that the government at least would set
    fees according to the size of the product's market.

    Prescription drugs
    ------------------
    ¶7. (SBU) On the other hand, the pharmaceutical industry sees the

    WELLINGTON 00000475  002 OF 002

    joint agency as an improvement over New Zealand's existing small and
    overtaxed regulatory regime, in which obtaining marketing approval
    for prescription medicines can take more than three years.  The
    agency also could represent a cost-savings by providing a single
    point of entry for both markets, as opposed to requiring a product
    license in each country.  The industry is concerned, however, about
    whether labeling rules and other such requirements could be met
    within three years.  It is advocating a five-year transition period.

    ¶8. (SBU) The drug industry also says it will withdraw support of the
    agency if the New Zealand government uses it as an excuse to ban
    direct-to-consumer advertising (DTCA), which some firms have
    employed to boost sales of unsubsidized medicines in New Zealand's
    tightly restricted market.  Australia allows only disease-based,
    awareness-building advertising, while New Zealand is the only
    country in the world besides the United States that allows the
    pharmaceutical industry to promote its products directly to the
    public.  (The government is reviewing its policy on
    direct-to-consumer advertising of prescription medicines, in
    preparation for drafting new legislation on the regulation of DTCA.
    Such legislation is necessary because the law that would enable New
    Zealand to participate in the joint agency also would repeal the
    Medicines Act 1981, which allows DTCA.)

    Comment
    -------
    ¶9. (SBU) The joint agency's higher regulatory costs could lead to a
    decline in sales of U.S. medical devices and other therapeutic
    products in New Zealand.  Failure to recognize FDA certification
    also would add a discriminatory barrier to U.S. medical devices.
    While the need for improving regulation of therapeutic products in
    New Zealand should be acknowledged, post suggests these concerns be
    raised in the Trade and Investment Framework Agreement talks with
    New Zealand scheduled for July 27.

    MCCORMICK

`